Amedisys, Inc. (AMED)

US — Healthcare Sector
Peers: ACHC  ADUS  EHC  ENSG  OPCH  UHS  SGRY  EHAB  PNTG  INNV  NHC  HCSG 

Automate Your Wheel Strategy on AMED

With Tiblio's Option Bot, you can configure your own wheel strategy including AMED - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol AMED
  • Rev/Share 72.3231
  • Book/Share 37.9677
  • PB 2.5715
  • Debt/Equity 0.3775
  • CurrentRatio 1.2885
  • ROIC 0.0494

 

  • MktCap 3087339772.0
  • FreeCF/Share 6.6855
  • PFCF 14.0821
  • PE 26.9672
  • Debt/Assets 0.2073
  • DivYield 0
  • ROE 0.0993

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

AMED or CHE: Which Is the Better Value Stock Right Now?
AMED, CHE
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?

Read More
image for news AMED or CHE: Which Is the Better Value Stock Right Now?
Are Medical Stocks Lagging Amedisys (AMED) This Year?
AMED
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Negative

Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.

Read More
image for news Are Medical Stocks Lagging Amedisys (AMED) This Year?
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?
AMED
Published: March 28, 2025 by: Zacks Investment Research
Sentiment: Positive

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

Read More
image for news Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?
Here's Why You Should Retain AMED Stock in Your Portfolio Now
AMED
Published: March 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

Read More
image for news Here's Why You Should Retain AMED Stock in Your Portfolio Now
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
AMED
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Neutral

While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More
image for news Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates
AMED
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Negative

Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago.

Read More
image for news Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
AMED
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024.

Read More
image for news Amedisys Reports Fourth Quarter and Year End 2024 Financial Results

About Amedisys, Inc. (AMED)

  • IPO Date 1994-08-17
  • Website https://www.amedisys.com
  • Industry Medical - Care Facilities
  • CEO Mr. Richard M. Ashworth
  • Employees 19000

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.